 |
市場調查報告書
商品編碼
2080049
糖化終產物（AGEs）市場規模、佔有率和成長分析：按產品類型、應用、技術、最終用戶、給藥方式、疾病領域和地區分類－2026-2033年產業預測Advanced glycation end products market Size, Share, and Growth Analysis, By Product Type, By Application, By Technology, By End User, By Offering, By Disease Area, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球糖化終產物(AGEs) 市值為 27.5 億美元，預計到 2025 年將成長至 29.1 億美元，到 2033 年將成長至 45.3 億美元，在預測期（2026-2033 年）內複合年成長率為 5.7%。
糖化終產物(AGEs) 市場在生物醫學和化妝品行業均呈現顯著成長，這主要得益於人們對 AGEs 對包括糖尿病和心血管疾病在內的慢性疾病影響的認知不斷提高。先前，AGEs 的研究主要局限於學術領域，但隨著飲食 AGEs 與健康狀況之間新的流行病學聯繫的出現，AGEs 市場湧現出多元化的商業性機會。各公司正積極研發檢測試劑盒、治療藥物和標靶膳食補充劑，尤其是在歐洲和美國等地區。監管機構要求降低加工食品中 AGEs 的含量，這迫使生產商推出創新解決方案並改進產品配方，從而推高了產品需求。此外，人口老化推動了 AGE 抑制劑臨床研究的蓬勃發展，吸引了大量投資，並拓展了包括膳食補充劑和藥品在內的多個細分市場的潛力。
全球糖化終產物（AGEs）市場成長要素
醫療專業人員對糖化終產物(AGEs) 對慢性疾病進展的顯著影響的認知不斷提高，推動了對早期檢測和預防措施的需求。這種認知的增強加速了對綜合檢測和治療方案的需求，促使製造商拓展產品線。隨著 AGE 監測日益融入標準診療流程，市場正經歷穩定成長，並在醫院、研究機構和專科診所廣泛應用。此外，隨著臨床醫生尋求針對 AGE 相關併發症的標靶策略，個人化醫療的興起也日益受到關注，進一步推動了市場的動態和擴張。
全球糖化終產物（AGEs）市場的限制因素
全球糖化終產物（AGEs）市場面臨許多挑戰，包括由於目標化合物合成涉及複雜的化學過程以及所需的大量檢驗而導致的巨額研發成本。高昂的生產成本，加上為確定安全性和有效性而需要進行的全面臨床試驗，推高了產品價格。這種經濟負擔可能會阻礙預算緊張的醫療機構採用新的療法，從而阻礙市場滲透。此外，這些經濟限制也阻礙了小規模生物技術公司進入市場，限制了競爭並阻礙了整體成長。這些壓力也使定價策略複雜化，影響保險報銷方案，並進一步限制了產品的推廣應用。
全球糖化終產物（AGEs）市場趨勢
全球糖化終產物(AGEs) 市場正經歷顯著成長趨勢，這主要得益於消費者對健康和保健日益成長的關注。隨著人們對 AGEs 與慢性疾病之間關聯的認知不斷加深，越來越多的人選擇能夠最大限度地減少這些化合物生成的飲食。為了應對這一轉變，食品製造商正在重新思考產品配方，例如減少糖分、降低烹飪溫度以及使用替代甜味劑，從而推動了低 AGE 原料和加工方法市場的快速成長。此外，對用於檢驗AGE 含量的分析服務、能夠維持營養價值的創新包裝解決方案以及原料供應商與注重健康的品牌之間的合作需求也在不斷成長，這些因素有效地拓展了全球市場價值鏈。
目錄
介紹
- 調查目的
- 市場定義和範圍
調查方法
- 研究過程
- 二級資料和一級資料的方法
- 市場規模估算方法
執行摘要
- 全球市場展望
- 市場主要亮點
- 細分市場概覽
- 競爭環境概述
市場動態及展望
- 總體經濟指標
- 促進者和機會
- 抑制因素和挑戰
- 供給面趨勢
- 需求面趨勢
- 波特的分析和影響
關鍵市場分析
- 關鍵成功因素
- 影響市場的因素
- 主要投資機會
- 生態系測繪
- 2025年市場魅力指數
- PESTLE分析
- 監理情勢
全球糖化終產物(AGEs) 市場規模：依產品類型分類
- AGE檢測方法
- AGE生物標記試劑
- 年齡調查工具包
- AGE抑制劑
- AGE Breaker
- 用於年齡測量的分析設備
全球糖化終產物(AGEs) 市場規模：依應用領域分類
- 糖尿病研究
- 心血管疾病研究
- 腎臟病學研究
- 老化研究
- 神經退化性疾病研究
- 藥物發現
全球糖化終產物(AGEs) 市場規模：依技術分類
- 採用酵素連結免疫吸附試驗（ELISA）法進行檢測
- 螢光檢測法
- 基於層析法的分析
- 質譜分析
- 免疫測量
全球糖化終產物(AGEs) 市場規模：依最終用戶分類
- 製藥公司
- 生技公司
- 學術研究機構
- 受託研究機構
- 診斷檢查室
全球糖化終產物(AGEs) 市場規模：依給藥途徑分類
- 研究試劑
- 檢測試劑盒
- 分析服務
- 研究設備
全球糖化終產物(AGEs) 市場規模：依疾病領域分類
- 糖尿病
- 心血管疾病
- 腎臟疾病
- 神經病變
- 與老齡化相關的疾病
全球糖化終產物（AGEs）市場規模：依地區分類
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
- 拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家
競爭資訊
- 前五大公司對比
- 主要公司2025年的市場定位
- 主要市場公司採取的策略
- 近期市場趨勢
- 企業市場占有率分析，2025 年
- 主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）
主要公司簡介
- Merck KGaA
- Thermo Fisher Scientific
- Danaher Corporation
- Bio-Rad Laboratories
- Agilent Technologies
- PerkinElmer
- Abcam
- Bio-Techne
- Cell Biolabs
- Cosmo Bio
- CUSABIO
- Elabscience Biotechnology
- MyBioSource
- Creative Diagnostics
- Abbexa
- RayBiotech
- Wuhan Fine Biotech
- Cloud-Clone Corp.
- Enzo Biochem
- Boster Biological Technology
結論與建議
Global Advanced Glycation End Products Market size was valued at USD 2.75 Billion in 2024 and is poised to grow from USD 2.91 Billion in 2025 to USD 4.53 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).
The market for Advanced Glycation End Products (AGEs) is experiencing significant growth in both biomedical and cosmetic industries due to increased recognition of their influence on chronic health conditions, including diabetes and cardiovascular diseases. Previously confined to academic research, the emerging epidemiological connections between dietary AGEs and health outcomes have opened diverse commercial opportunities. Companies are actively developing detection kits, therapeutic agents, and targeted nutraceuticals, particularly in regions like Europe and the United States. Regulatory pressures to reduce AGE levels in processed foods are pushing manufacturers to adopt innovative solutions and reformulate products, resulting in heightened product demand. Additionally, increased clinical research on AGE-blocking therapeutics, driven by an aging population, is attracting investment and expanding market potential across multiple segments, including nutraceuticals and pharmaceuticals.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Advanced Glycation End Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Advanced Glycation End Products Market Segments Analysis
Global advanced glycation end products market is segmented by product type, application, technology, end user, offering, disease area and region. Based on product type, the market is segmented into AGE detection assays, AGE biomarker reagents, AGE research kits, AGE inhibitors, AGE breakers and analytical instruments for AGE measurement. Based on application, the market is segmented into diabetes research, cardiovascular disease research, nephrology research, aging research, neurodegenerative disease research and drug discovery. Based on technology, the market is segmented into elisa-based detection, fluorescence-based detection, chromatography-based analysis, mass spectrometry-based analysis and immunoassays. Based on end user, the market is segmented into pharmaceutical companies, biotechnology companies, academic research institutes, contract research organizations and diagnostic laboratories. Based on offering, the market is segmented into research reagents, assay kits, analytical services and research instruments. Based on disease area, the market is segmented into diabetes, cardiovascular disorders, renal disorders, neurological disorders and aging-related conditions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Advanced Glycation End Products Market
The rising recognition among healthcare professionals of the significant impact advanced glycation end products (AGEs) have on chronic disease progression is fueling demand for early detection and preventive measures. This increased awareness is driving the need for comprehensive testing solutions and therapeutic options, motivating manufacturers to broaden their product offerings. As AGEs monitoring becomes more integrated into standard care practices, the market is experiencing consistent growth, with wider adoption across hospitals, research institutions, and specialty clinics. Moreover, the shift towards personalized medicine enhances interest, as clinicians pursue targeted strategies to address AGE-related complications, further reinforcing market dynamics and expansion.
Restraints in the Global Advanced Glycation End Products Market
The Global Advanced Glycation End Products market faces significant challenges due to the intricate chemical processes involved in synthesizing targeted compounds and the extensive validation required, which considerably inflate research expenditures. High production costs coupled with the need for comprehensive clinical trials to establish safety and efficacy result in elevated product prices. This financial burden may deter budget-limited healthcare providers from adopting new therapies, consequently hindering market penetration. Additionally, these economic constraints dissuade smaller biotech companies from entering the market, thereby limiting competition and stifling overall growth. Such pressures also complicate pricing strategies, affecting reimbursement options and further inhibiting product utilization.
Market Trends of the Global Advanced Glycation End Products Market
The Global Advanced Glycation End Products (AGEs) market is witnessing a significant trend driven by a rising consumer focus on health and wellness. As awareness grows regarding the relationship between AGEs and chronic diseases, individuals are increasingly opting for diets that minimize the formation of these compounds. This shift has prompted food manufacturers to adapt by reformulating products to reduce sugar levels, lower cooking temperatures, and utilize alternative sweeteners, thus creating a burgeoning market for low-AGE ingredients and processing methods. Additionally, there is a growing demand for analytical services to verify AGE content, innovative packaging solutions that maintain nutritional integrity, and collaborative partnerships between ingredient suppliers and health-conscious brands, effectively broadening the market's global value chain.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Advanced glycation end products market Size by Product Type & CAGR (2026-2033)
- Market Overview
- AGE Detection Assays
- AGE Biomarker Reagents
- AGE Research Kits
- AGE Inhibitors
- AGE Breakers
- Analytical Instruments for AGE Measurement
Global Advanced glycation end products market Size by Application & CAGR (2026-2033)
- Market Overview
- Diabetes Research
- Cardiovascular Disease Research
- Nephrology Research
- Aging Research
- Neurodegenerative Disease Research
- Drug Discovery
Global Advanced glycation end products market Size by Technology & CAGR (2026-2033)
- Market Overview
- ELISA-based Detection
- Fluorescence-based Detection
- Chromatography-based Analysis
- Mass Spectrometry-based Analysis
- Immunoassays
Global Advanced glycation end products market Size by End User & CAGR (2026-2033)
- Market Overview
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Diagnostic Laboratories
Global Advanced glycation end products market Size by Offering & CAGR (2026-2033)
- Market Overview
- Research Reagents
- Assay Kits
- Analytical Services
- Research Instruments
Global Advanced glycation end products market Size by Disease Area & CAGR (2026-2033)
- Market Overview
- Diabetes
- Cardiovascular Disorders
- Renal Disorders
- Neurological Disorders
- Aging-related Conditions
Global Advanced glycation end products market Size & CAGR (2026-2033)
- North America (Product Type, Application, Technology, End User, Offering, Disease Area)
- US
- Canada
- Europe (Product Type, Application, Technology, End User, Offering, Disease Area)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, Technology, End User, Offering, Disease Area)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, Technology, End User, Offering, Disease Area)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, Technology, End User, Offering, Disease Area)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abcam
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cosmo Bio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CUSABIO
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elabscience Biotechnology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MyBioSource
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbexa
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RayBiotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wuhan Fine Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cloud-Clone Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Biochem
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boster Biological Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
